| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Toxoplasma gondii tachyzoite-bradyzoite interconversion.
|
Trends Parasitol
|
2002
|
1.58
|
|
2
|
Evolutionary origins of the eukaryotic shikimate pathway: gene fusions, horizontal gene transfer, and endosymbiotic replacements.
|
Eukaryot Cell
|
2006
|
1.44
|
|
3
|
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection.
|
J Neuroinflammation
|
2008
|
1.41
|
|
4
|
Vaccines against Toxoplasma gondii: challenges and opportunities.
|
Mem Inst Oswaldo Cruz
|
2009
|
1.39
|
|
5
|
Maternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host.
|
Eukaryot Cell
|
2005
|
1.37
|
|
6
|
IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii.
|
Eur J Immunol
|
2010
|
1.27
|
|
7
|
Parasite regulation by host hormones: an old mechanism of host exploitation?
|
Trends Parasitol
|
2005
|
1.16
|
|
8
|
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
|
PLoS Negl Trop Dis
|
2008
|
1.10
|
|
9
|
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.
|
Antimicrob Agents Chemother
|
2012
|
1.07
|
|
10
|
Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba.
|
J Clin Microbiol
|
2005
|
1.01
|
|
11
|
Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids.
|
Biochemistry
|
2007
|
1.00
|
|
12
|
Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors.
|
Immunology
|
2008
|
0.99
|
|
13
|
DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission.
|
Vaccine
|
2003
|
0.98
|
|
14
|
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
|
Acta Crystallogr D Biol Crystallogr
|
2007
|
0.98
|
|
15
|
In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain.
|
J Immunol
|
2002
|
0.97
|
|
16
|
Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase.
|
J Med Chem
|
2010
|
0.95
|
|
17
|
Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
|
Hum Immunol
|
2011
|
0.94
|
|
18
|
The unusual mitochondrial compartment of Cryptosporidium parvum.
|
Trends Parasitol
|
2005
|
0.93
|
|
19
|
Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone.
|
J Immunol
|
2010
|
0.93
|
|
20
|
Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
|
Antimicrob Agents Chemother
|
2005
|
0.92
|
|
21
|
Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion.
|
Infect Immun
|
2005
|
0.86
|
|
22
|
Immunological control of congenital toxoplasmosis in the murine model.
|
Immunol Lett
|
2007
|
0.84
|
|
23
|
Immunogenetics of Toxoplasma gondii informs vaccine design.
|
Trends Parasitol
|
2010
|
0.84
|
|
24
|
Selective inhibition and augmentation of alternative macrophage activation by progesterone.
|
Immunology
|
2011
|
0.84
|
|
25
|
Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.
|
Bioorg Med Chem Lett
|
2013
|
0.84
|
|
26
|
Differential cytotoxicity of phospholipid analogues to pathogenic Acanthamoeba species and mammalian cells.
|
J Antimicrob Chemother
|
2007
|
0.84
|
|
27
|
Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase.
|
Acta Crystallogr Sect F Struct Biol Cryst Commun
|
2006
|
0.83
|
|
28
|
Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.
|
Antimicrob Agents Chemother
|
2007
|
0.81
|
|
29
|
MAP kinase phosphatase-2 plays a key role in the control of infection with Toxoplasma gondii by modulating iNOS and arginase-1 activities in mice.
|
PLoS Pathog
|
2013
|
0.79
|
|
30
|
Biochemical and immunological characterization of Toxoplasma gondii macrophage migration inhibitory factor.
|
J Biol Chem
|
2013
|
0.78
|
|
31
|
Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
|
ChemMedChem
|
2013
|
0.77
|
|
32
|
Acanthamoeba alternative oxidase genes: identification, characterisation and potential as antimicrobial targets.
|
Int J Parasitol
|
2009
|
0.75
|